A haploidentical may be a better choice than a female genoidentical donor to transplant a patient with high risk acute myelogenous leukemia in first remission

Norbert Gorin, Myriam Labopin, Didier Blaise, Goda Choi, Gerard Socie, Jean Henri Bourhis, Fabio Ciceri, Emmanuelle Polge, Arnon Nagler, Mohamad Mohty

    Research output: Contribution to journalMeeting AbstractAcademic

    Original languageEnglish
    Pages (from-to)564-564
    Number of pages1
    JournalBone marrow transplantation
    Volume54
    Publication statusPublished - Jul-2019
    Event45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT) - Frankfurt, Germany
    Duration: 24-Mar-201927-Mar-2019

    Cite this